Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Analysis of the verbatim from the transcription of the recorded interviews..
- Кому может быть актуально
- Состояния в реестре: Stroke. Базовые параметры: 65 лет — 100 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Франция
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
Подробное описание
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. The probability of stroke recurrence is high: about 25% the first year , and 30 to 40% in the 5 years following the stroke. Recurrent strokes are responsible for significant disability, institutionalization, major neurocognitive disorders, and death.
In order to reduce the risk of stroke recurrence, multiple secondary prevention strategies have demonstrated their effectiveness, such as the prescription of drugs (in particular statins and antithrombotics), the establishment of a balanced diet, the practice of an activity physical, or even tobacco addiction.
However, the effectiveness of these strategies is optimal if and only if patients adhere to them.
In addition, previous studies have focused on the brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
In elderly patients, other obstacles could have been identified by specific studies, such as cognitive, sensory, functional disorders or even isolation.
Вмешательства
- Другое Analysis of the verbatim from the transcription of the recorded interviews.
recorded semi-structured interviews between the patients and the pharmacist
Первичные конечные точки
- Analysis of the verbatim from the transcription of the recorded interviews. [Срок оценки: one year]
Вторичные конечные точки (4)
- Analysis of verbatim statements from the transcription of recorded interviews on patients' representations and beliefs regarding antithrombotics [Срок оценки: 15 to 60 minutes per patient]
- Analysis of verbatim statements from the transcription of recorded interviews on patients' medication adherence to antithrombotics [Срок оценки: 15 to 60 minutes per patient]
- Analysis of verbatim statements from the transcription of recorded interviews on the impact of the occurrence of stroke or recurrence of stroke on medication adherence [Срок оценки: 15 to 60 minutes per patient]
- Analysis of verbatim statements from the transcription of recorded interviews on the obstacles and levers to medication adherence [Срок оценки: 15 to 60 minutes per patient]
Критерии участия
Критерии включения
- Patients aged 65 and over
- Patients hospitalized for an ischemic stroke or a recurrence of ischemic stroke, already being treated with an antithrombotic treatment (antiplatelet agent or anticoagulant ) prior to the stroke
- Patients living at home and with a plan to return home.
- Patients who did not object to the study and who gave their consent for the recording of the interview
Критерии исключения
- Patients with cognitive disorders or stroke sequelae that do not allow a semi-directive interview to be carried out (at medical discretion).
- Non-French speaking patients
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Другое
Центры проведения
Франция · 1 центр
- institute of aging - Hôpital des Charpennes — Villeurbanne
Идентификаторы
NCT: NCT05741593 · 69HCL22_1074 · 2023-A00181-44